Literature DB >> 15887869

21-Hydroxylase deficiency: from molecular genetics to clinical presentation.

E Trakakis1, D Laggas, E Salamalekis, G Creatsas.   

Abstract

Congenital adrenal hyperplasia due to deficiency of the enzyme 21-hydroxylase (21-OH), a cytochrome P450 enzyme located in the endoplasmic reticulum and which catalyzes the conversion of 17-hydroxyprogesterone to 11-deoxycortisol and progestene to deoxycorticosterone, is distinguished in its classical and non-classical form and is also one of the most common autosomal recessive inherited diseases in humans. The classical form appears in a rate between 1:5000 and 1:15,000 among the live neonates of North America and Europe, while the non-classical form occurs in approximately 0.2% of the general white population. This rate is especially high between the Ahskenazi Jews and a part (ie Italians, Hispanics) of the Mediterranean populations. Three alleles are associated with the 21-OH locus and can be combined in several ways in individuals who are either unaffected, heterozygote carriers, or affected with classical or non-classical disease. Variable signs and symptoms of hyperandrogenism, such as hirsutism, acne, virilization of the external genitalia and/or the body, short stature, menstrual irregularities, are common to both types of the disorder. Among the genes responsible for the synthesis of the enzyme 21-OH and the antigens of HLA system, exist both a proven genetic linkage and a proven genetic linkage disequilibrium. HLA-Bw47, HLAB5 and HLA-B35 are the most common haplotypes usually met in the classical form, while the haplotype HLA-B14DR1 is the most recurrent in the non-classical form of the disease. The significant advances in molecular biology and gene analysis over the past two decades have led to the development of novel sensitive methods of DNA analysis and study, such as polymerase chain reaction and southern blot analysis. Thus, it has been revealed that the synthesis of enzyme 21-OH is controlled by two genes, the active CYP21B gene and the CYP21A pseudogene. All three forms of the disease have a known sequence of gene changes owing to mutations in isolated proteins or whole series of genes due to translocations or deletions of genetic material.

Entities:  

Mesh:

Year:  2005        PMID: 15887869     DOI: 10.1007/bf03345366

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  45 in total

Review 1.  Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Y Morel; W L Miller
Journal:  Adv Hum Genet       Date:  1991

2.  High frequency of nonclassical steroid 21-hydroxylase deficiency.

Authors:  P W Speiser; B Dupont; P Rubinstein; A Piazza; A Kastelan; M I New
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

3.  Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency.

Authors:  T A Bachega; A E Billerbeck; G Madureira; J A Marcondes; C A Longui; M V Leite; I J Arnhold; B B Mendonca
Journal:  J Clin Endocrinol Metab       Date:  1998-12       Impact factor: 5.958

Review 4.  Late onset congenital adrenal hyperplasia: a gynecologist's perspective.

Authors:  B L Brodie; A C Wentz
Journal:  Fertil Steril       Date:  1987-08       Impact factor: 7.329

Review 5.  Genetics of steroid 21-hydroxylase deficiency.

Authors:  P C White
Journal:  Recent Prog Horm Res       Date:  1987

6.  Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia.

Authors:  L S Levine; B Dupont; F Lorenzen; S Pang; M Pollack; S Oberfield; B Kohn; A Lerner; E Cacciari; F Mantero; A Cassio; C Scaroni; G Chiumello; G F Rondanini; L Gargantini; G Giovannelli; R Virdis; E Bartolotta; C Migliori; C Pintor; L Tato; F Barboni; M I New
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

7.  A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.

Authors:  P W Speiser; E S Knochenhauer; D Dewailly; F Fruzzetti; J A Marcondes; R Azziz
Journal:  Mol Genet Metab       Date:  2000-11       Impact factor: 4.797

8.  Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms.

Authors:  G Rumsby; C J Avey; G S Conway; J W Honour
Journal:  Clin Endocrinol (Oxf)       Date:  1998-06       Impact factor: 3.478

Review 9.  Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling.

Authors:  P W Speiser
Journal:  Am J Pharmacogenomics       Date:  2001

10.  HLA linkage and B14, DR1, BfS haplotype association with the genes for late onset and cryptic 21-hydroxylase deficiency.

Authors:  M S Pollack; L S Levine; G J O'Neill; S Pang; F Lorenzen; B Kohn; G F Rondanini; G Chiumello; M I New; B Dupont
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

View more
  3 in total

1.  Genotype, phenotype and hormonal levels correlation in non-classical congenital adrenal hyperplasia.

Authors:  S Einaudi; E Napolitano; F Restivo; G Motta; M Baldi; G Tuli; E Grosso; N Migone; E Menegatti; C Manieri
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

Review 2.  Reflections on the diseases linked to mutations of the androgen receptor.

Authors:  Angelo Poletti; Paola Negri-Cesi; Luciano Martini
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.925

3.  Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P).

Authors:  Justin T Brown; Cora Lahey; Walairat Laosinchai-Wolf; Andrew G Hadd
Journal:  BMC Med Genet       Date:  2006-08-03       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.